Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending October 26, 2024 (Week 43)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 14,021 35,799 1,149,343 1,384,623
New England 130 1,128 36,920 45,092
Connecticut 8 296 6,583 10,993
Maine - 81 2,131 2,456
Massachusetts 8 647 21,695 23,959
New Hampshire - 67 1,952 2,374
Rhode Island 90 389 3,524 4,208
Vermont 24 33 1,035 1,102
Middle Atlantic 2,367 4,237 152,906 167,163
New Jersey 456 748 27,922 29,903
New York (excluding New York City) 810 955 32,511 35,543
New York City 516 1,500 50,322 56,078
Pennsylvania 585 1,168 42,151 45,639
East North Central 1,345 4,573 143,911 189,797
Illinois 18 1,438 34,804 58,511
Indiana 315 698 25,769 28,583
Michigan 166 910 24,059 35,758
Ohio 662 1,153 40,613 46,067
Wisconsin 184 517 18,666 20,878
West North Central 825 1,987 72,068 81,653
Iowa 112 299 9,801 11,548
Kansas 147 288 9,714 11,292
Minnesota 157 486 16,304 18,177
Missouri 317 648 23,958 25,891
Nebraska - 208 6,333 7,717
North Dakota 45 87 2,536 2,879
South Dakota 47 108 3,422 4,149
South Atlantic 3,111 12,281 273,459 318,557
Delaware - 199 4,155 4,712
District of Columbia 21 177 5,516 7,106
Florida 1,584 6,933 88,748 94,049
Georgia - 1,476 45,062 61,066
Maryland - 930 23,535 30,016
North Carolina 4 1,436 44,507 55,553
South Carolina 756 820 27,310 27,688
Virginia 711 912 31,243 34,684
West Virginia 35 112 3,383 3,683
East South Central 1,097 2,748 50,303 89,431
Alabama 641 889 26,116 28,052
Kentucky 379 592 13,465 13,940
Mississippi 77 1,006 10,722 16,557
Tennessee - 834 - 30,882
West South Central 900 4,646 163,514 188,738
Arkansas 183 399 13,038 15,108
Louisiana 330 750 27,198 30,535
Oklahoma 43 407 8,919 16,523
Texas 344 3,262 114,359 126,572
Mountain 1,343 2,691 86,504 97,085
Arizona 379 846 30,967 34,530
Colorado 522 857 19,945 21,332
Idaho 59 124 4,213 4,856
Montana 35 98 2,691 3,034
Nevada 186 344 12,322 13,157
New Mexico - 229 7,145 9,405
Utah 162 239 8,300 9,229
Wyoming - 47 921 1,542
Pacific 2,903 4,838 169,758 207,107
Alaska 71 125 3,908 4,289
California 2,149 3,800 139,326 161,089
Hawaii - 145 - 5,318
Oregon 324 353 11,588 12,844
Washington 359 562 14,936 23,567
U.S. Territories - 121 667 4,377
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 121 667 4,377
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 4 4 39 43
Total 14,025 35,844 1,150,049 1,389,043
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.